| THEA Pharma S.A. - Softacort 3,35 mg/ml, Collyre | | 67980 | | 01 | | Softacort 3,35 mg/ml | | Collyre | | S01BA02 | | Hydrocortison | | 21.06.2021 | | |
| | Composition | | hydrocortisoni phosphas natricus 3.35 mg, dinatrii phosphas dodecahydricus, natrii dihydrogenophosphas monohydricus, natrii chloridum, dinatrii edetas, acidum hydrochloridum concentratum, aqua ad iniectabile ad solutionem pro 1 ml corresp. phosphas 7 mg. | | Packungsbestandteile | | Collyre | | | | | | Principe actif | Concentr. |
|---|
| Hydrocortisoni Phosphas Natricus | 3.35 mg/ml |
| | | | Agents auxilliaires |
|---|
| Acidum Hydrochloridum Concentratum | | Dinatrii Edetas | | Disodium Phosphate Dodecahydrate | | Sodium Chlorure | | Sodium Dihydrogenophosphate Monohydrate |
|
| |
|
